NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
Clinical Trials
8 trialsNCT05233098 2025-03-06
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Completed
NCT03483922 2024-07-05
HCC Screening Using DNA Methylation Changes in ctDNA
HKGepitherapeutics
Completed
NCT00605150 2022-04-22
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
Wake Forest University Health Sciences
Completed
NCT02670122 2021-03-30
Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz
Completed
NCT01446666 2019-02-01
PRIUS
Asan Medical Center
Completed
NCT01043523 2016-11-28
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Bayer
Completed
NCT01549275 2015-10-08
Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed